In simple words: Penile cancer on the shaft of the penis. It's rare and may be caused by HPV or other factors like smoking. Symptoms include sores, rashes, bleeding, and pain. Doctors diagnose it through exams and biopsies, and treatment may involve surgery, chemotherapy, or radiation.

Malignant neoplasm of the body of the penis, a rare cancer on or in the penis. The primary risk factor is thought to be HPV, although other risk factors include smoking, advanced age, genetic predisposition, and chronic STDs.Symptoms may include a non-healing sore or rash, change in skin color, unusual discharge, bleeding, difficulty retracting foreskin, and painful intercourse. If the cancer spreads to nearby tissues via lymphatic ducts or blood vessels, it can be fatal if not detected early. Diagnosis is based on patient history, physical examination, symptoms, and signs, in addition to cystoscopy, proctoscopy, and ultrasound to determine if the cancer has spread to the bladder, rectum, or other organs. A penile biopsy is typically performed. Lymph node biopsy and imaging tests (X-ray, CT, MRI, PET) are used for staging. Treatment includes chemotherapy, radiation therapy, surgical excision with reconstruction, or penectomy.

Example 1: A 55-year-old male presents with a non-healing sore on the shaft of his penis. After examination and biopsy, a diagnosis of squamous cell carcinoma of the penis is confirmed, localized to the body of the penis. C60.2 is used for coding., A 70-year-old male with a history of HPV infection reports bleeding from his penis. A biopsy reveals invasive squamous cell carcinoma of the penile shaft. C60.2 is assigned as the diagnosis code., A male patient with a previously excised penile lesion on the glans now presents with a new lesion on the shaft. Biopsy confirms a recurrence of squamous cell carcinoma. C60.2 is the appropriate code for this new lesion location.

Documentation should include details of the lesion's location (body of penis), size, appearance, any associated symptoms, results of the biopsy confirming malignancy, and staging information derived from imaging and other investigations.